Pacer Advisors, Inc. Pacira Bio Sciences, Inc. Transaction History
Pacer Advisors, Inc.
- $41.8 Billion
- Q3 2024
A detailed history of Pacer Advisors, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 4,962,221 shares of PCRX stock, worth $95.3 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
4,962,221
Previous 2,162,787
129.44%
Holding current value
$95.3 Million
Previous $61.9 Million
20.77%
% of portfolio
0.18%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding PCRX
# of Institutions
263Shares Held
50.4MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$154 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$102 Million0.0% of portfolio
-
State Street Corp Boston, MA2.01MShares$38.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$38 Million0.05% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.96MShares$37.6 Million0.03% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $880M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...